Extended Data Fig. 5: SPR analysis of human TCR mimic scFv.
From: Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
a SPR analysis for individual NY-ESO1 clones expressed as scFv format. NY-ESO1/HLA-A*02:01 was immobilized on SA chip as ligand. Serial diluted NY-ESO1 specific clones were injected as analyte. b SPR analysis for individual MART1 clones expressed as scFv format. MART1/HLA-A*02:01 was immobilized on SA chip as ligand. Serial diluted MART1 specific clones were injected as analyte. c SPR analysis for individual GP100 clones experessed as scFv format. GP100/HLA-A*02:01 was immobilized on SA chip as ligand. Serial diluted GP100 specific clones were injected as analyte. d SPR analysis for individual KRAS clones expressed as scFv format. KRAS/HLA-A*02:01 was immobilized on SA chip as ligand. Serial diluted KRAS specific clones were injected as analyte.
